RA Capital Healthcare Fund LP, Director, 10% Owner at Climb Bio, Inc. (CLYM), bought 7,111 shares at $3.50 ($25K) on 2026-01-05, disclosed to the SEC on 2026-01-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| PEPG | BUY | 2025-09-30 | $30.0M | — | Filing → |
| TYRA | BUY | 2025-06-11 | $3.8M | — | Filing → |
| JANX | BUY | 2025-03-07 | $50.7M | — | Filing → |